drugset / Trial / NCT05440734
Exogenous Melatonin in Postmenopausal Women with Insomnia
Terminated
6 enrolled
Douglas Mental Health University Institute
Canadian Institutes of Health Research (CIHR) · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The aim of the study is to assess the effect of exogenous melatonin, 2 mg SR, 60 minutes before bedtime for 15 days, on the sleep and circadian rhythms of postmenopausal women with insomnia in a randomized crossover placebo-controlled study.
Timeline
- Start
- 2022-06-17
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melatonin | Small molecule | 2 mg | Oral |